Invention Application
- Patent Title: TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
-
Application No.: US17503516Application Date: 2021-10-18
-
Publication No.: US20220119388A1Publication Date: 2022-04-21
- Inventor: Guanglin Luo , Jie Chen , Carolyn Diane Dzierba , David B. Frennesson , Junqing Guo , Amy C. Hart , Xirui Hu , Michael C. Mertzman , Matthew Reiser Patton , Jianliang Shi , Steven H. Spergel , Brian Lee Venables , Yong-Jin Wu , Zili Xiao , Michael G. Yang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Public/Granted literature
- US11767322B2 Triazolopyridinyl compounds as kinase inhibitors Public/Granted day:2023-09-26
Information query
